期刊文献+

人绝经期促性腺激素诱发排卵风险的远期随访:附21例分析 被引量:3

Long term follow-up studies after treatment with gonadotropin for induction of ovulation
在线阅读 下载PDF
导出
摘要 目的:随访早年使用促性腺激素治疗不孕症的妇女用药后的相应情况和子女情况。方法:本研究随访了1985年-1998年期间21例应用促性腺激素后得孕生子的不孕症病人的身体状况及子女情况,对所有对象进行病吏询问、妇科检查、宫颈防癌涂片、乳房检查、生殖激素和CA-125的测定以及了解是否患有子宫颈癌、子宫内膜癌、卵巢癌和乳腺癌,同时咨询子女的健康和智力情况。结果:21例病人妇科检查、防癌涂片、乳房检查、妇科B超以及CA-125均未发现异常;5例垂体性闭经者,已届绝经期年龄,血中促卵泡素(FSH)、黄体生成激素(LH)、催乳素(PRL)及雌二醇(E2)值呈低反应。本组分娩婴儿单胎13人,双胎8对,除1女婴产后8d死亡外,存活28人,现年7~23a不等,均未发现明显畸形,均健康、智力发育良好。结论:21例病人用促性腺激素促排卵治疗受孕生育后7~23a,未发现有生殖道癌肿,子代健康、智力正常。 AIM: To follow-up study the health condition and next generations of infertility patients after ovulation induction with gonadotropin. METHODS: Twenty-one patients during 1985-1998 were collected and consulted with genital condition, pelvic examination, papanicolaou' s smear, pelvic ultrasound B scan, breast examination, reproductive hormones, CA-125 as well as their children' s condition. RESULTS: All those examinations did not found any abnormity in the 21 patients, of which 5 patients in menopause suffered from pituitary amenorrhea with lower values of the blood FSH, LH, E2, and PRL. There are 13 single babies and 8 twins, with 12 male and 17 female. One female infant died 8 d after born, so the total is 28 babies. All babies now aged from 7 - 23 a are healthy with normal intelligence. CONCLUSION: Any genital cancer and breast cancer do not be found in 21 infertility patients treated with gonadotropin for ovulation induction and their babies are healthy.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2007年第8期593-596,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 促性腺激素类 排卵诱导 随访研究 不育 gonadotropins ovulation induction follow-up studies infertility
  • 相关文献

参考文献10

  • 1邵敬於 梁红妹.人绝经期促性腺激素的临床应用.上海医学,1986,9(8):454-459.
  • 2VENN A,WATSON L,BRUINSMA F,et al.Risk of cancer after use of fertility drugs with in-vitro fertilization[J].Lancet,1999,354(9190):1586-1590.
  • 3朱丽萍.诱发排卵的不良影响[M]//邵敬於.人类诱发排卵.上海:上海复旦大学出版社,2006:424-425.
  • 4周灿权.诱发排卵和排卵[M]//庄广伦.现代辅助生殖技术.北京:人民卫生出版社,2005:108.
  • 5BRINTON LA,SCOCCIA B,MOGHISSI KS,et al.Breast cancer risk associated with ovulation-stimulating drugs[J].Hum Reprod,2004,19(9):2005-2013.
  • 6GAUTHIER E,PAOLETTI X,CLAVEL-CHAPELON F,et al.Breast cancer risk associated with being treated for infertility:results from the French E3N cohort study[J].Hum Reprod,2004,19(10):2216-2221.
  • 7BRINTON LA,LAMB EJ,MOGHISSI KS,et al.Ovarian cancer risk after the use of ovulation-stimulating drugs[J].Obstet Gynecol,2004,103(6):1194-1203.
  • 8SALHAB M,ai SARAKBI W,MOKBEL K.In vitro fertilization and breast cancer risk:a review[J].Int J Fertil Womens Med,2005,50(6):259-266.
  • 9ALTHUIS MD,SCOCCIA B,LAMB EJ,et al.Melanoma,thyroid,cervical,and colon cancer risk after use of fertility drugs[J].Am J Obstet Gynecol,2005,193(3 Pt 1):668-674.
  • 10KLIP H,BURGER CW,KENEMANS P,et al.Cancer risk associated with subfertility and ovulation induction:a review[J].Cancer Causes Control,2000,11(4):319-344.

共引文献1

同被引文献23

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部